Corvus Energy, Bergen, Norway, recently announced that it has received type approval from Lloyd’s Register (LR) for its ...

The battle between man and machine begins on Saturday with the Botswana Motor Sport (BMS) National Cross-County Championship ...

Dominic Norton discusses focusing on the shift to digital vulnerabilities, including securing IoT devices in the public ...

Senior legal voices from the world’s biggest companies share perspective on International Women’s Day theme | Action is key ...

The Library ID is at the end of the LinkedIn Learning invitation link, example below www.linkedin.com/learning-login/go/libraryID Please contact your librarian for ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.

US pharma major Bristol Myers Squibb has announced positive data from the pivotal Phase III POETYK PsA-2 trial evaluating the ...

US pharma major Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) plus ...

By: Mark Freeman - Offer Manager, Digital Buildings, Anglophone Africa at Schneider Electric Africa is now an urban continent ...

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will ...